Clinical Trials Directory

Trials / Completed

CompletedNCT04052165

IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient

IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Glaucoma is a group of diseases that damage the eye's optic nerve, result in progressive visual field defect and blindness. The aim of glaucoma management is to reduce IOP, and glaucoma implant surgery is the alternative treatment that can be chosen. The effectiveness of the implant on the end stage glaucoma patients was evaluated by the reduction of intra ocular pressure (IOP) and well formed blebs that were evaluated clinically and by using anterior scanning optical coherence tomography (AS-OCT). The safety of the implant was determined by the regression of the clinical symptoms and there were no severe complications such as implant extrusion. Two patients developed improvement of the visual acuity. This was an unpredictable positive result.

Detailed description

The study is to measure the efficacy of new GDD that made with polymethyl methacrylate. The primary outcome is IOP reduction. The secondary outcome is glaucoma medication post surgery and complication that occurred during the follow up. The subjects are refractory glaucoma patients that need glaucoma drainage device implantation. The measurement are collected on first day, first month, third month, sixth month and twelve month. The IOP will be measured using GAT (Goldmann applanation tonometer), but if the subjects are not cooperative, they will be measured using i-care. On the follow up, the glaucoma medication needed will be noted and also for the complication and the need for other surgery, e.g. AC formation using viscoelastic, repair tube/plate exposure, cyclo photocoagulation, etc.

Conditions

Interventions

TypeNameDescription
PROCEDUREGlaucoma Implant

Timeline

Start date
2015-07-01
Primary completion
2019-08-01
Completion
2020-08-08
First posted
2019-08-09
Last updated
2021-08-25

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04052165. Inclusion in this directory is not an endorsement.